Correlation Between ARCA Biopharma and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both ARCA Biopharma and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARCA Biopharma and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARCA Biopharma and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on ARCA Biopharma and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARCA Biopharma with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARCA Biopharma and Acrivon Therapeutics,.
Diversification Opportunities for ARCA Biopharma and Acrivon Therapeutics,
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ARCA and Acrivon is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding ARCA Biopharma and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and ARCA Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARCA Biopharma are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of ARCA Biopharma i.e., ARCA Biopharma and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between ARCA Biopharma and Acrivon Therapeutics,
Given the investment horizon of 90 days ARCA Biopharma is expected to under-perform the Acrivon Therapeutics,. In addition to that, ARCA Biopharma is 1.92 times more volatile than Acrivon Therapeutics, Common. It trades about -0.02 of its total potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.07 per unit of volatility. If you would invest 420.00 in Acrivon Therapeutics, Common on September 3, 2024 and sell it today you would earn a total of 338.00 from holding Acrivon Therapeutics, Common or generate 80.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 72.37% |
| Values | Daily Returns |
ARCA Biopharma vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| ARCA Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Acrivon Therapeutics, |
ARCA Biopharma and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ARCA Biopharma and Acrivon Therapeutics,
The main advantage of trading using opposite ARCA Biopharma and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARCA Biopharma position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| ARCA Biopharma vs. Aerovate Therapeutics | ARCA Biopharma vs. Adagene | ARCA Biopharma vs. Acrivon Therapeutics, Common | ARCA Biopharma vs. Rezolute |
| Acrivon Therapeutics, vs. Milestone Pharmaceuticals | Acrivon Therapeutics, vs. Seres Therapeutics | Acrivon Therapeutics, vs. DiaMedica Therapeutics | Acrivon Therapeutics, vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |